Psychosocial Screening for Neuroendocrine Tumor Patients
- Conditions
- Neuroendocrine Tumors
- Registration Number
- NCT03372356
- Lead Sponsor
- Peking University
- Brief Summary
This is a psychosocial screening application to usual care in a cohort of neuroendocrine tumor patients. The application involves monitoring using the NCCN Distress Thermometer(DT), Hospital Anxiety and Depression Scale(HADS), Self-Perceived Burden Scale(SPBS) and Connor-Davidson Resilience Scale(CD-RISC). These assessments will be completed at baseline, 3 months, 6 months, 12 months and 24 months. Patients will have the option of filling out questionnaires more frequently if desired.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- sign written informed consent form;
- age ≥ 18 years;
- pathologically confirmed well-differentiated neuroendocrine tumors, G1-2 (Ki67≤20%);
Exclusion Criteria
- <18 years;
- Neuroendocrine carcinoma;
- History of psychiatric or psychologic illness;
- History of previous cancers or cancer distress;
- Patients with central nervous system(CNS) disorder；
- Severe, uncontrolled medical condition that would affect patients' compliance;
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method DT every 3 month until 24 month Distress Thermometer
- Secondary Outcome Measures
Name Time Method HADS every 3 month until 24 month Hospital Anxiety and Depression Scale
SPBS every 3 month until 24 month Self-Perceived Burden Scale
CD-RISC every 3 month until 24 month Connor-Davidson Resilience Scale
Trial Locations
- Locations (1)
Beijing Cancer Hospital
🇨🇳Beijing, Beijing, China